|
[1]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Brain Tumors. Final Report (Protocol BT-10)
Journal of Cancer Therapy,
2017
DOI:10.4236/jct.2017.82015
|
|
|
|
|
[2]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Children with Low-Grade Astrocytomas—Final Report (Protocol BT-13)
Journal of Cancer Therapy,
2016
DOI:10.4236/jct.2016.712083
|
|
|
|
|
[3]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Adult Patients with Primary Brain Tumors—Final Report (Protocol BT-09)
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.612116
|
|
|
|
|
[4]
|
A Phase II Study of Antineoplastons A10 and AS2-1 in Patients with Brainstem Gliomas. The Report on Non-Diffuse Intrinsic Pontine Glioma (Protocol BT-11)
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.64036
|
|
|
|
|
[5]
|
A Case of Sustained Objective Response of Recurrent/Progressive Diffuse Intrinsic Pontine Glioma with Phenylbutyrate and Targeted Agents
Journal of Cancer Therapy,
2015
DOI:10.4236/jct.2015.61006
|
|
|
|
|
[6]
|
Long-Term Survival Over 21 Years and Pathologically Confirmed Complete Response in Pediatric Anaplastic Astrocytoma: A Case Report
Journal of Neurology & Stroke,
2015
DOI:10.15406/jnsk.2015.02.00072
|
|
|
|
|
[7]
|
Long-Term Survival (Over 20 Years), Complete Response and Normal Childhood Development in Medulloblastoma Treated with Antineoplastons A10 and AS2-1
Journal of Neurology & Stroke,
2015
DOI:10.15406/jnsk.2015.02.00054
|
|
|
|
|
[8]
|
The Effect of Antineoplastons A10 and AS2-1 and Metabolites of Sodium Phenylbutyrate on Gene Expression in Glioblastoma Multiforme
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.510099
|
|
|
|
|
[9]
|
Recurrent Glioblastoma Multiforme—A Strategy for Long-Term Survival
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.510101
|
|
|
|
|
[10]
|
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Advanced Malignant Mesothelioma: A Strategy for Improved Survival
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.512116
|
|
|
|
|
[11]
|
Preliminary Findings on the Use of Targeted Therapy with Pazopanib and Other Agents in Combination with Sodium Phenylbutyrate in the Treatment of Glioblastoma Multiforme
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.514144
|
|
|
|
|
[12]
|
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Recurrent Advanced Pancreatic Cancer—A Potential Strategy for Improved Survival
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.512113
|
|
|
|
|
[13]
|
Preliminary Findings on the Use of Targeted Therapy in Combination with Sodium Phenylbutyrate in Colorectal Cancer after Failure of Second-Line Therapy—A Potential Strategy for Improved Survival
Journal of Cancer Therapy,
2014
DOI:10.4236/jct.2014.513128
|
|
|
|